FSSAI Advises Importers to Declare Non-Food Grade Items in Bills of Entry Using NFG Qualifier
Posted by: Prabhas Chakraborty August 24, 2026
Read More
FSSAI Clarifies Regulatory Position on Use of Identical Flavours in Alcoholic Beverages
Posted by: Prabhas Chakraborty August 24, 2026
Read MoreFSSAI Proposes Thresholds for Foods High in Added Fat, Added Sugar and Salt in Schools
Posted by: Prabhas Chakraborty August 24, 2026
Read MoreGuidance on product category under Compulsory Registration Scheme (CRS)
Posted by: Hitesh Gupta August 20, 2026
Read MoreClarification on the submission of applications for grant of Permission to Import and Market New Drugs not approved anywhere in the world, wherein Phase III Global Clinical Trials (GCT) are ongoing or completed with participation of Indian subjects under the New Drugs and Clinical Trials Rules, 2019
Posted by: Hitesh Gupta August 13, 2026
Read More- 7
- Comments Off on Clarification on the submission of applications for grant of Permission to Import and Market New Drugs not approved anywhere in the world, wherein Phase III Global Clinical Trials (GCT) are ongoing or completed with participation of Indian subjects under the New Drugs and Clinical Trials Rules, 2019
- 13th August, 2026
Amendment to Rule 89 of the Drugs Rules, 1945 for obtaining licence under Form 29 for additional manufacturing licence categories
Posted by: Hitesh Gupta August 13, 2026
Read MoreGovernment Clarifies Status of AI-Based Breast Cancer Screening under the National Programme for Prevention and Control of Non-Communicable Diseases (NP-NCD)
Posted by: Prabhas Chakraborty August 10, 2026
Read MoreNPPA Issues Clarifications on Filing of Form-IA for New Drugs under the Drugs (Prices Control) Amendment Order, 2026
Posted by: Prabhas Chakraborty August 10, 2026
Read More